Cargando…
Evidence for Inflammation as a Driver of Atrial Fibrillation
Atrial fibrillation (AF) is one of the most common types of arrhythmias and increases cardiovascular morbidity and mortality. Current therapeutic approaches to AF that focus on rhythm control have high recurrence rates and no life prolongation value. While possible explanations include toxicity of c...
Autores principales: | Zhou, Xiaoxu, Dudley, Samuel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201086/ https://www.ncbi.nlm.nih.gov/pubmed/32411723 http://dx.doi.org/10.3389/fcvm.2020.00062 |
Ejemplares similares
-
Editorial: Novel strategies for persistent atrial fibrillation ablation and AF driver mapping
por: Qin, Mu, et al.
Publicado: (2023) -
Effect of Digoxin Therapy on Mortality in Patients With Atrial Fibrillation: An Updated Meta-Analysis
por: Wang, Xiaoxu, et al.
Publicado: (2021) -
A novel approach for quantitative electrogram analysis for driver identification: Implications for ablation in persistent atrial fibrillation
por: Shi, Wen-Rui, et al.
Publicado: (2022) -
Modified Taiwan Atrial Fibrillation Score for the Prediction of Incident Atrial Fibrillation
por: Liao, Jo-Nan, et al.
Publicado: (2022) -
Association of Serum Biomarkers and Cardiac Inflammation in Patients With Atrial Fibrillation: Identification by Positron Emission Tomography
por: Chen, Bi-Xi, et al.
Publicado: (2021)